Assessing the impact of a safe and equitable biosimilar policy in the United States : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, May 2, 2007

• Record Nr.: UNINA9910694419603321
• Descrizione fisica: 1 online resource (vi, 184 p.) : ill
• Soggetti: Biologicals - United States; Pharmaceutical biotechnology - United States; Generic drugs - United States
• Lingua di pubblicazione: Inglese
• Formato: Materiale a stampa
• Livello bibliografico: Monografia